Patients' adherence to secondary prevention pharmacotherapy after acute coronary syndromes

ISSN： 2210-7703

Source： International Journal of Clinical Pharmacy, Vol.35, Iss.2, 2013-04, pp. : 275-280

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clopidogrel: Potential In the Prevention of Cardiovascular Events in Patients with Acute Coronary Syndromes

By Easthope S.E. Jarvis B.

American Journal of Cardiovascular Drugs, Vol. 1, Iss. 6, 2001-06 ,pp. : 467-474

Adis International

Access to resources Recommend Favorite

Increasing adherence to guideline-recommended therapies is associated with decreased mortality in patients aged ≥ 90 years with acute coronary syndromes

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 530, 2007-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Cost-Effective Pharmacological Prevention of Acute Coronary Syndromes

By Monaco C. Cianflone D. Summaria F. Maseri A. Crea F.

Pharmacological Research, Vol. 37, Iss. 6, 1998-06 ,pp. : 469-475

Academic Press

Access to resources Recommend Favorite

Pharmacotherapy of Acute Coronary Syndromes: Medical Economics with an Emphasis on Clopidogrel

By Bramkamp Matthias Dedes Konstantin Szucs Thomas

Cardiovascular Drugs and Therapy, Vol. 19, Iss. 4, 2005-08 ,pp. : 291-299

Springer Publishing Company

Access to resources Recommend Favorite

Secondary prevention after acute MI

Inpharma, Vol. 1, Iss. 1430, 2004-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite